Progressive Myositis Ossificans — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for progressive myositis ossificans. 45 active patents protecting 1 drugs from 1+ originators. First major cliff: 2031. Daily refresh.

Approved drugs

Active US patents

75/100

Avg vulnerability

$200M

Annual revenue covered

Originators in Progressive Myositis Ossificans

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Ipsen 45 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating progressive myositis ossificans. Each bar = one year. Y-axis scaled to peak year (25 patents).

Approved drugs ranked by patent estate

Drug	Originator	Active patents	Avg vuln	Revenue	First cliff
Sohonos PALOVAROTENE	Ipsen	45	75	$200M	2031-08-31

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent	Drug	Type	Vuln	Expiry
12023312	Sohonos	method of use	81	2031-08-31
12023312	Sohonos	method of use	81	2031-08-31
12023312	Sohonos	method of use	81	2031-08-31
12023312	Sohonos	method of use	81	2031-08-31
12023312	Sohonos	method of use	81	2031-08-31
10292954	Sohonos	method of use	76	2031-08-31
10292954	Sohonos	method of use	76	2031-08-31
9314439	Sohonos	method of use	76	2031-08-31
9789074	Sohonos	method of use	76	2031-08-31
10292954	Sohonos	method of use	76	2031-08-31

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent	Drug	Type	Vuln	Expiry
11622959	Sohonos	method of use	70	2037-06-08
11622959	Sohonos	method of use	70	2037-06-08
10864194	Sohonos	method of use	70	2037-06-08
11622959	Sohonos	method of use	70	2037-06-08
11622959	Sohonos	method of use	70	2037-06-08
10864194	Sohonos	method of use	70	2037-06-08
10864194	Sohonos	method of use	70	2037-06-08
10864194	Sohonos	method of use	70	2037-06-08
11622959	Sohonos	method of use	70	2037-06-08
10864194	Sohonos	method of use	70	2037-06-08

Progressive Myositis Ossificans — full disease profile
AI Patent Landscape Report — type "progressive myositis ossificans" for an AI exec memo
Company Patent Rankings
Biosimilar Opportunity Scanner